A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34).
Mustjoki
Satu
S
Hernesniemi
Sari
S
Rauhala
Auvo
A
Kähkönen
Marketta
M
Almqvist
Anders
A
Lundán
Tuija
T
Porkka
Kimmo
K
D000328:Adult; D000595:Amino Acid Sequence; D000069439:Dasatinib; D050939:Gene Fusion / Q000235:genetics; D016313:Genes, abl / Q000235:genetics*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D008297:Male; D008969:Molecular Sequence Data; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D054448:Precursor Cells, B-Lymphoid / Q000187:drug effects / Q000502:physiology*; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use*; D014178:Translocation, Genetic / Q000235:genetics*
D047908:Intracellular Signaling Peptides and Proteins; D011743:Pyrimidines; C506059:RCSD1 protein, human; D013844:Thiazoles; D000069439:Dasatinib